Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor
Gregorio D. Chazenbalk, … , Sandra M. McLachlan, Basil Rapoport
Gregorio D. Chazenbalk, … , Sandra M. McLachlan, Basil Rapoport
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):209-217. https://doi.org/10.1172/JCI15745.
View: Text | PDF
Article Aging

Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor

  • Text
  • PDF
Abstract

Research Article

Authors

Gregorio D. Chazenbalk, Pavel Pichurin, Chun-Rong Chen, Francesco Latrofa, Alan P. Johnstone, Sandra M. McLachlan, Basil Rapoport

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
(a) TSH covalent cross-linking to intact cells reveals greater level of ...
(a) TSH covalent cross-linking to intact cells reveals greater level of cell surface TSHR expression in TSHR-10,000 cells than in ECD-GPI cells. After simultaneous 125I-TSH cross-linking (same number of cells, same amount of 125I-TSH), cell extracts were subjected to polyacrylamide gel electrophoresis (10%) under reducing conditions (see Methods). Autoradiography (representative of three experiments) was for 16 hours. In lanes 1 and 2, equal volumes of cell extract were applied. Lanes 3 and 4 were loaded with equal amounts of radioactivity. TSH cross-linking to intact cells, unlike immunoprecipitation (b), visualizes only mature TSHR expressed on the cell surface. Two forms of TSHR are seen: single-chain uncleaved TSHR and the ligand binding A subunit in the cleaved TSHR released from the serpentine region (TSHR-10,000 cells) or from the GPI-anchored portion (ECD-GPI) by disulfide bond reduction. Note the lesser proportion of cleaved versus uncleaved receptors in the ectodomain with the GPI anchor than in the wild-type TSHR. (b) Immunoprecipitation confirms higher level of TSHR expression in TSHR-10,000 cells than in ECD-GPI cells. Similar numbers of TSHR-10,000 cells and ECD-GPI cells were precursor labeled simultaneously with the same quantity of 35S-methionine and 35S-cysteine (see Methods). Detergent-solubilized particulate preparations were immunoprecipitated with murine mAb A9 (epitope in the midregion of the TSHR ectodomain), the most effective mAb available to us for immunoprecipitating all forms of the TSHR. After polyacrylamide gel electrophoresis (10%), autoradiography (representative of duplicate experiments) was performed for 16 hours.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts